Leslie A McClure1, Dawn O Kleindorfer2, Brett M Kissela2, Mary Cushman2, Elsayed Z Soliman2, George Howard2. 1. From the Department of Biostatistics, University of Alabama at Birmingham (L.A.M., G.H.); Department of Neurology, University of Cincinnati, OH (D.O.K., B.M.K.); Department of Medicine, University of Vermont, Burlington (M.C.); and Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC (E.Z.S.). lmcclure@uab.edu. 2. From the Department of Biostatistics, University of Alabama at Birmingham (L.A.M., G.H.); Department of Neurology, University of Cincinnati, OH (D.O.K., B.M.K.); Department of Medicine, University of Vermont, Burlington (M.C.); and Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC (E.Z.S.).
Abstract
BACKGROUND AND PURPOSE: The most well-known stroke risk score is the Framingham Stroke Risk Score (FSRS), which was developed during the higher stroke risk period of the 1990s and has not been validated for blacks. We assessed the performance of the FSRS among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study to determine whether it is useful in both blacks and whites. METHODS: Expected annualized stroke rates from the FSRS were compared with observed stroke rates overall and within strata defined by FSRS risk factors (age, sex, systolic blood pressure, use of antihypertensive medications, diabetes mellitus, smoking, atrial fibrillation, left ventricular hypertrophy, and prevalent coronary heart disease). RESULTS: Among 27 748 participants stroke-free at baseline, 715 stroke events occurred over 5.6 years of follow-up. FSRS-estimated incidence rates of stroke were 1.6× higher than observed for black men, 1.9× higher for white men, 1.7× higher for black women, and 1.7× higher for white women. This overestimation was consistent among most subgroups of FSRS factors, although the magnitude of overestimation varied by the risk factor assessed. CONCLUSIONS: Although higher FSRS was associated with higher stroke risk, the FSRS overestimated the observed stroke rates in this study, particularly in certain subgroups. This may be because of temporal declines in stroke rates, secular trends in prevention treatments, or differences in populations studied. More accurate estimates of event rates are critical for planning research, including clinical trials, and targeting health-care efforts.
BACKGROUND AND PURPOSE: The most well-known stroke risk score is the Framingham Stroke Risk Score (FSRS), which was developed during the higher stroke risk period of the 1990s and has not been validated for blacks. We assessed the performance of the FSRS among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study to determine whether it is useful in both blacks and whites. METHODS: Expected annualized stroke rates from the FSRS were compared with observed stroke rates overall and within strata defined by FSRS risk factors (age, sex, systolic blood pressure, use of antihypertensive medications, diabetes mellitus, smoking, atrial fibrillation, left ventricular hypertrophy, and prevalent coronary heart disease). RESULTS: Among 27 748 participantsstroke-free at baseline, 715 stroke events occurred over 5.6 years of follow-up. FSRS-estimated incidence rates of stroke were 1.6× higher than observed for black men, 1.9× higher for white men, 1.7× higher for black women, and 1.7× higher for white women. This overestimation was consistent among most subgroups of FSRS factors, although the magnitude of overestimation varied by the risk factor assessed. CONCLUSIONS: Although higher FSRS was associated with higher stroke risk, the FSRS overestimated the observed stroke rates in this study, particularly in certain subgroups. This may be because of temporal declines in stroke rates, secular trends in prevention treatments, or differences in populations studied. More accurate estimates of event rates are critical for planning research, including clinical trials, and targeting health-care efforts.
Authors: Susanna L Matsen; David C Chang; Bruce A Perler; Glen S Roseborough; G Melville Williams Journal: J Vasc Surg Date: 2006-09 Impact factor: 4.268
Authors: Carole Dufouil; Alexa Beiser; Leslie A McLure; Philip A Wolf; Christophe Tzourio; Virginia J Howard; Andrew J Westwood; Jayandra J Himali; Lisa Sullivan; Hugo J Aparicio; Margaret Kelly-Hayes; Karen Ritchie; Carlos S Kase; Aleksandra Pikula; Jose R Romero; Ralph B D'Agostino; Cécilia Samieri; Ramachandran S Vasan; Genevieve Chêne; George Howard; Sudha Seshadri Journal: Circulation Date: 2017-02-03 Impact factor: 29.690
Authors: Gabriel S Tajeu; Stephen Mennemeyer; Nir Menachemi; Robert Weech-Maldonado; Meredith Kilgore Journal: Med Care Date: 2017-06 Impact factor: 2.983
Authors: Nita A Limdi; Virginia J Howard; John Higginbotham; Jason Parton; Monika M Safford; George Howard Journal: J Racial Ethn Health Disparities Date: 2015-11-05
Authors: Agni Orfanoudaki; Emma Chesley; Christian Cadisch; Barry Stein; Amre Nouh; Mark J Alberts; Dimitris Bertsimas Journal: PLoS One Date: 2020-05-21 Impact factor: 3.240
Authors: Priya Parmar; Rita Krishnamurthi; M Arfan Ikram; Albert Hofman; Saira S Mirza; Yury Varakin; Michael Kravchenko; Michael Piradov; Amanda G Thrift; Bo Norrving; Wenzhi Wang; Dipes Kumar Mandal; Suzanne Barker-Collo; Ramesh Sahathevan; Stephen Davis; Gustavo Saposnik; Miia Kivipelto; Shireen Sindi; Natan M Bornstein; Maurice Giroud; Yannick Béjot; Michael Brainin; Richie Poulton; K M Venkat Narayan; Manuel Correia; António Freire; Yoshihiro Kokubo; David Wiebers; George Mensah; Nasser F BinDhim; P Alan Barber; Jeyaraj Durai Pandian; Graeme J Hankey; Man Mohan Mehndiratta; Shobhana Azhagammal; Norlinah Mohd Ibrahim; Max Abbott; Elaine Rush; Patria Hume; Tasleem Hussein; Rohit Bhattacharjee; Mitali Purohit; Valery L Feigin Journal: Int J Stroke Date: 2014-12-10 Impact factor: 5.266
Authors: Xueyan Zhao; Xin Geng; Vinodh Srinivasasainagendra; Ninad Chaudhary; Suzanne Judd; Virginia Wadley; Orlando M Gutiérrez; Henry Wang; Ethan M Lange; Leslie A Lange; Daniel Woo; Frederick W Unverzagt; Monika Safford; Mary Cushman; Nita Limdi; Rakale Quarells; Donna K Arnett; Marguerite R Irvin; Degui Zhi Journal: BMC Med Genomics Date: 2019-01-31 Impact factor: 3.063